Jump to main content
Jump to site search

Issue 9, 2018
Previous Article Next Article

Recent advances in nanoparticle-based lateral flow immunoassay as a point-of-care diagnostic tool for infectious agents and diseases

Author affiliations

Abstract

Lateral flow immunoassay (LFIA) technology is a paper-based, point-of-care strip biosensor designed to detect a specific analyte in a given sample. This type of assay is now of great interest to researchers for its cost-effectiveness, simplicity, portability and rapidness of detection of analytes, including but not limited to areas such as agriculture, food, biomedicine and pathogen detection. Various nanoparticles (such as metal nanoparticles, carbon-based nanoparticles, quantum dots, lanthanides and up-converting phosphor) functionalized by an antibody to detect an analyte protein or molecular marker present in the surface of an infectious pathogen are used for in LFIAs. Herein, we review the principle of the assay and recent advancements made in terms of the different approaches and designs of the assay towards the detection of infectious agents and diseases.

Graphical abstract: Recent advances in nanoparticle-based lateral flow immunoassay as a point-of-care diagnostic tool for infectious agents and diseases

Back to tab navigation

Publication details

The article was received on 16 Feb 2018, accepted on 19 Mar 2018 and first published on 20 Mar 2018


Article type: Critical Review
DOI: 10.1039/C8AN00307F
Citation: Analyst, 2018,143, 1970-1996
  •   Request permissions

    Recent advances in nanoparticle-based lateral flow immunoassay as a point-of-care diagnostic tool for infectious agents and diseases

    R. Banerjee and A. Jaiswal, Analyst, 2018, 143, 1970
    DOI: 10.1039/C8AN00307F

Search articles by author

Spotlight

Advertisements